novo nordisk tirzepatide FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by and Eli Lilly Novo Nordisk's 'Semaglutide' gains weight

The FDA's enforcement posture regarding compounded GLP-1 medications has evolved significantly in early 2026

He is one of 167 of the victims who have come forward and sought a total of $78,317 (58,169) compensation for the damage caused

Given the immense popularity of GLP-1 receptor agonists for weight loss and diabetes management, semaglutide could soon be recognized not just as a metabolic therapy but as a potential neuroprotective agent , offering hope for millions at risk of Alzheimers

While there are many websites offering these medications for less, there is no way of knowing where these medications are compounded or where they are coming from

In rodent animal models, GLP-1RAs increased thyroid paracellular cell (C-cell) proliferation and the incidence of tumors

fatty-acid acylation to enable reversible albumin binding and prolong systemic half-life [22]